11/26
07:00 am
lptx
Leap Therapeutics to Participate at Piper Sandler 36th Annual Healthcare Conference
Medium
Report
Leap Therapeutics to Participate at Piper Sandler 36th Annual Healthcare Conference
11/15
08:02 am
lptx
Leap Therapeutics, Inc. (NASDAQ: LPTX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $5.50 price target on the stock.
Medium
Report
Leap Therapeutics, Inc. (NASDAQ: LPTX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $5.50 price target on the stock.
11/13
07:00 am
lptx
Leap Therapeutics Reports Third Quarter 2024 Financial Results
Medium
Report
Leap Therapeutics Reports Third Quarter 2024 Financial Results
9/30
07:00 am
lptx
Leap Therapeutics Announces Completion of Enrollment in Part B of the DeFianCe Study of DKN-01 for the Treatment of Colorectal Cancer Patients
Medium
Report
Leap Therapeutics Announces Completion of Enrollment in Part B of the DeFianCe Study of DKN-01 for the Treatment of Colorectal Cancer Patients